Independent Article - Reactor Closure Puts Medical Scans At Risk As Shortage Of Radioactive Material Could Jeopardise Patients’ Health
The Independent newspaper published an article on the radioisotope shortage with quotes from Dr Brian Neilly, President BNMS, Prof Alan Perkins, Past-Presdient BNMS and Prof Erika Denton, national clinical director for diagnostics at NHS England.
Please follow this link to read full article here
Professor Alan Perkins, Professor of Medical Physics at the University of Nottingham and Past-President of the BNMS, writes an article on the radioisotope shortage for 'The Conversation' which you can read here at theconversation.com
Panel of MO-99 Producers say Supplies Are Secure, Outline Investments made to bolster Future of Supply
Please read or download the following press release from Curium
Further to our previous communication regarding Indium Oxine and Chloride withdrawal from the european market, please see the following message from the UK radiopharmacy group about alternative methods for labelling blood cells with In-111 Indium Chloride:
Below is a link for your information is the latest update from the AIPES ERT group on the continuing NTP problem and also some advice about a recent Generator Facility problem in Australia. The next ERT meeting is scheduled for 9 July 2018.
Please note that there has not been a problem with either the OPAL Reactor or Processing facility and that international shipments of bulk 99Mo have continued as scheduled. Please consult the ANSTO website (http://www.ansto.gov.au/AboutANSTO/MediaCentre/News/ACS181901) for correct information.
We will continue to monitor the supply situation closely, if you are regularly experiencing shortages at the moment, please let us know the details.
Communicaton below from Jean-Michel Vanderhofstadt, Director General AIPES and Bernard Ponsard, Chairman ERT
Mo---99 Production Activities at NTP Radioisotopes (NTP)